TREATMENT OF INFECTED TUNNELED VENOUS ACCESS HEMODIALYSIS CATHETERS WITH GUIDEWIRE EXCHANGE

Citation
D. Robinson et al., TREATMENT OF INFECTED TUNNELED VENOUS ACCESS HEMODIALYSIS CATHETERS WITH GUIDEWIRE EXCHANGE, Kidney international, 53(6), 1998, pp. 1792-1794
Citations number
17
Categorie Soggetti
Urology & Nephrology
Journal title
ISSN journal
00852538
Volume
53
Issue
6
Year of publication
1998
Pages
1792 - 1794
Database
ISI
SICI code
0085-2538(1998)53:6<1792:TOITVA>2.0.ZU;2-C
Abstract
Cuffed venous access catheters have become commonplace for hemodialysi s access. The major complications of these catheters are catheter thro mbosis, catheter fibrin sheathing and infection. When catheter associa ted bacteremia occurs treatment with antimicrobial therapy alone has b een unsuccessful in providing acceptable cure rates. Failed antimicrob ial therapy exposes the patient to the risks of prolonged bacteremia, while the alternative, catheter replacement at a new site can lead to central venous stenosis and compromise future long-term upper extremit y access. Catheter guidewire exchange when the tunnel tract is clinica lly not infected theoretically allows the preservation of future acces s sites and yields a higher treatment success rate while avoiding temp orary non-cuffed access placement. We report a series of 23 cases of h emodialysis patients with tunneled cuffed catheters and bacteremia rel ated to the catheter who were treated with the exchange of a new cathe ter over a guidewire combined with three weeks of systemic antibiotics . Patients eligible for the study required no evidence of tunnel tract infection and defervescence within 48 hours of antimicrobial therapy. Technique failure was defined as repeat infection from any organism w ithin 90 days of catheter exchange. Four patients (18%) redeveloped ba cteremia within 90 days of the exchange. The bacteremias developed at 4, 19, 63 and at 74 days days after the exchange. Guidewire exchange i n combination with intravenous antibiotics in cases of catheter relate d bacteremia has an acceptable rate of treatment success and is a viab le treatment option in a carefully selected patient population.